Clinical trial
Post Marketing Surveillance Program of Praxbind Use in India.
NCT03359889 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance Program of Praxbind Use in India.
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 26, 2018
- Completion date
- January 13, 2020
- Enrollment
- 5 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.